VRCI — Verici Dx Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro CapSucker Stock
- £20.44m
- £7.77m
Annual cashflow statement for Verici Dx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 December 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | PROSPECTUS | ARS |
Standards: | IFRS | IFRS |
Status: | Final | Final |
Net Income/Starting Line | -0.084 | -8.33 |
Depreciation | ||
Amortisation | ||
Non-Cash Items | 0.028 | 0.741 |
Other Non-Cash Items | ||
Changes in Working Capital | 0.011 | 0.815 |
Change in Accounts Receivable | ||
Change in Payable / Accrued Expenses | ||
Change in Other Liabilities | ||
Other Operating Cash Flow | ||
Cash from Operating Activities | 0 | -6.34 |
Capital Expenditures | — | -0.966 |
Purchase of Fixed Assets | ||
Purchase / Acquisition of Intangibles | ||
Cash from Investing Activities | — | -0.966 |
Financing Cash Flow Items | — | 0 |
Other Financing Cash Flow | ||
Net Issuance / Retirement of Stock | ||
Net Issuance / Retirement of Debt | ||
Cash from Financing Activities | 0 | -0.074 |
Foreign Exchange Effects | ||
Beginning Cash Balance | ||
Ending Cash Balance | ||
Net Change in Cash | 0 | -7.41 |